| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Mycobacterium fortuitum (ATCC 6841) |
- |
- |
≤0.125 － ? |
Minocycline (Minocycline hydrochloride, Minocin)  |
471 |
| Mycobacterium fortuitum (ATCC 6841) |
- |
- |
≤0.25 － ? |
Doxycycline (Doxycycline hyclate, Doxy, Vibra, Vibramycin) |
471 |
| Mycobacterium fortuitum (ATCC 6841) |
- |
- |
0.5 － ? |
Isoniazid (INH, Laniazid, Nydrazid, Rifamate) |
226 |
| Mycobacterium fortuitum (ATCC 6841) |
- |
- |
0.5 － ? |
Isoniazid (INH, Laniazid, Nydrazid, Rifamate) |
346 |
| Mycobacterium fortuitum (ATCC 6841) |
- |
- |
0.5 － ? |
Tetracycline (Sumycin, Achromycin V, Steclin) |
471 |
| Mycobacterium fortuitum (ATCC 6841) |
- |
- |
2 － ? |
Isoniazid (INH, Laniazid, Nydrazid, Rifamate) |
1084 |
| Mycobacterium fortuitum (ATCC 6841) |
- |
- |
4 － ? |
Ethambutol (Myambutol) |
346 |
| Mycobacterium fortuitum (ATCC 6841) |
- |
- |
4 － ? |
Linoleic acid |
346 |
| Mycobacterium fortuitum (ATCC 6841) |
- |
- |
8 － ? |
Ethambutol (Myambutol) |
226 |
| Mycobacterium fortuitum (ATCC 6841) |
- |
- |
8 － ? |
Falcarindiol |
226 |
| Mycobacterium fortuitum (ATCC 6841) |
- |
- |
16 － ? |
8-Hydroxy canthin-6-one |
998 |
| Mycobacterium fortuitum (ATCC 6841) |
- |
- |
16 － ? |
Canthin-6-one |
998 |
| Mycobacterium fortuitum (ATCC 6841) |
- |
- |
16 － ? |
Oleic acid |
346 |
| Mycobacterium fortuitum (ATCC 6841) |
- |
- |
16 － ? |
Tobramycin (Tobrex, Nebcin) |
459 |
| Mycobacterium fortuitum (ATCC 6841) |
- |
- |
>32 － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
1084 |
| Mycobacterium fortuitum (ATCC 6841) |
- |
- |
>32 － ? |
Ranbezolid (RBX 7644) |
1084 |
| Mycobacterium fortuitum (ATCC 6841) |
- |
- |
>32 － ? |
RBx 8700 |
1084 |
| Mycobacterium fortuitum (ATCC 6841) |
- |
- |
>32 － ? |
Rifampicin (Rifampin) |
1084 |
| Mycobacterium fortuitum (ATCC 6841) |
- |
- |
32 － ? |
Tobramycin (Tobrex, Nebcin) |
453 |
| Mycobacterium fortuitum (ATCC 6841) |
- |
- |
512 － ? |
Palmitic acid |
346 |
| Mycobacterium fortuitum (ATCC 6841) |
- |
- |
512 － ? |
Palmitic acid |
346 |
| Mycobacterium fortuitum (clinical isolate) |
- |
- |
2 － ? |
Isoniazid (INH, Laniazid, Nydrazid, Rifamate) |
1084 |
| Mycobacterium fortuitum (clinical isolate) |
- |
- |
>32 － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
1084 |
| Mycobacterium fortuitum (clinical isolate) |
- |
- |
>32 － ? |
Ranbezolid (RBX 7644) |
1084 |
| Mycobacterium fortuitum (clinical isolate) |
- |
- |
>32 － ? |
RBx 8700 |
1084 |
| Mycobacterium fortuitum (clinical isolate) |
- |
- |
>32 － ? |
Rifampicin (Rifampin) |
1084 |
| Mycobacterium fortuitum (group + tetracycline-resistant) |
≤0.06 |
≤0.12 |
≤0.06 － <=0.12 |
Tigecycline (GAR-936, Tigacyl) |
471 |
| Mycobacterium fortuitum (group + tetracycline-resistant) |
16 |
32 |
16 － 64 |
Tetracycline (Sumycin, Achromycin V, Steclin) |
471 |